Risk-tiered brand list
For risk-averse patients. Brands grouped by safety-first criteria: FDA-approved meds only, outcome transparency, NAMS-certified providers, insurance billing. Tier 1 = most conservative. Use if you prioritize regulatory clarity over price.
Tier 1 — Safest (2)
FDA-approved meds only + NAMS-cert + outcome data published + insurance billing.
Tier 2 — Cautious (4)
Mix of FDA + compounded. Has clinical methodology. Maybe not NAMS-cert.
Tier 3 — Acceptable (35)
Primarily compounded or cash-pay model. No major red flags.
Risk tiers explained
Tiers are deterministic from brand fields (score, outcomes, insurance, FDA-vs-compounded). Not subjective ranking. Tier 1 prioritizes regulatory clarity over price; Tier 3 prioritizes price over regulatory verification. Not medical recommendation — discuss with clinician.